Pyxis Oncology (PYXS) Net Cash Flow (QoQ) (2021 - 2025)
Pyxis Oncology (PYXS) Net Cash Flow (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Pyxis Oncology | 166.54 Mn | 99.69 Mn | 8.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 458.49% |
| Sep 30, 2025 | 7.40% |
| Jun 30, 2025 | 70.82% |
| Mar 31, 2025 | -190.52% |
| Dec 31, 2024 | 156.97% |
| Sep 30, 2024 | -349.98% |
| Jun 30, 2024 | -115.81% |
| Mar 31, 2024 | 462.36% |
| Dec 31, 2023 | 54.83% |
| Sep 30, 2023 | 66.40% |
| Jun 30, 2023 | 73.63% |
| Mar 31, 2023 | -555.93% |
| Dec 31, 2022 | 22.45% |
| Sep 30, 2022 | -4.10% |
| Jun 30, 2022 | 13.78% |
| Mar 31, 2022 | -119.37% |
| Dec 31, 2021 | 1,686.61% |
| Sep 30, 2021 | -597.29% |
| Jun 30, 2021 | -98.64% |
| Mar 31, 2021 | 4,287.74% |